Talk:American Journal of Transplantation
This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||
|
Updated article, but I have COI
[edit]This edit request by an editor with a conflict of interest was declined. The request was not specific enough. You may consider leaving your comments on the Talk page or escalating significant issues to the conflict of interest noticeboard. |
I am the editorial assistant for the American Journal of Transplantation, so I don't feel quite comfortable posting this article due to COI issues. I've tried to cite secondary sources; however, most of the information was gathered from front matter of the journal itself or the website. I've tried to omit claims that cannot be backed up by a secondary source. I will accept any edits deemed necessary by consensus.
The existing paragraph will remain.
Journal Scope (heading)
The American Journal of Transplantation is directed at scientists and clinicians in the broad field of transplantation including organ and tissue donation; drugs, pharmacology, and immunology as they relate to transplantation; graft survival; complications in transplantation; xenotransplantation; basic science as it relates to transplants; and ethical issues. The journal publishes articles across a wide range of organs and tissues, including thoracic (heart, lung), abdominal (intestine, kidney, liver, pancreas), vascularized composite allografts (face, hand), cells (hepatocytes, pancreatic islets), and related topics. The journal’s Aims and Scope say it “serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science in this dynamic field.”Cite error: The <ref>
tag has too many names (see the help page).
History (heading) The journal was founded in 2001 with Dr. Philip F. Halloran of the University of Alberta, Canada, serving as its first Editor-in-Chief[1]. In 2011, Dr. Allan D. Kirk succeeded Dr. Halloran as Editor-in-Chief, and the journal moved its offices to Emory University in Atlanta, Ga.[2] Dr. Halloran holds the title Editor Emeritus[3].
Four times a year since 2011, AJT has published a shorter, Czech-language version of the journal, which contains five articles originally published in the AJT. The local editor is Dr. Ondrej Viklický of the Institute for Clinical and Experimental Medicine in Prague, Czech Republic.[4]
The journal publishes one or two supplements per year on specialized topics within the field of transplantation. Supplements are peer-reviewed. Past special-topic supplements have included "Cytomegalovirus and Human Herpesvirus Infections in Solid Organ Transplant"[5] and "Focus on Small Bowel Transplantation: Selected Works from the XII International Small Bowel Transplant Symposium."[6]
AJT also publishes a Scientific Registry of Transplant Recipients (SRTR) supplement, a collection of data about transplant patients[7], each year. Another annual supplement is the collected abstracts submitted to the American Transplant Congress (ATC); the abstracts are peer-reviewed[8]. AJT’s final annual supplement is the ASTS’ State of the Art Winter Symposium supplement, which is published in January and contains the schedule, abstracts, and other information about the Symposium. To date, AJT has published three Infectious Disease Guidelines supplements (2004, 2009, and 2013). Again, articles in the Infectious Disease Guidelines are peer-reviewed, and new articles to the supplement are also reviewed by all the supplement’s editors[9].
Each month, AJT offers continuing medical education in the form of its Images in Transplantation feature. The article is a case-based approach that allows surgeons “the opportunity to explore images illustrating a clinical problem.”[10]
Abstracting and Indexing (heading)
The journal is indexed by the following abstracting and indexing services:
Academic Search (EBSCO)
Academic Search Elite (EBSCO)
Academic Search Premier (EBSCO)
BIOBASE: Current Awareness in Biological Sciences (Elsevier)
CAB Abstracts® (CABI)
CAB Health (CABI)
CABDirect (CABI)
CAS: Chemical Abstracts Service (CAS)
CSA Biological Sciences Database (CSA/CIG)
CSA Environmental Sciences & Pollution Management Database (CSA/CIG)
CSA Immunological Abstracts (CSA/CIG)
Current Contents: Clinical Medicine (Thomson ISI)
EMBASE (Elsevier)
HEED: Health Economic Evaluations Database (Wiley-Blackwell)
PubMed Dietary Supplement Subset (PMDSS, formerly IBIDS: International Bibliographic Information on Dietary Supplements)
Index Medicus/MEDLINE (NLM)
ISI Alerting Services (including Research Alert)
Journal Citation Reports/Science Edition (Thomson ISI)
Leisure Recreation and Tourism Abstracts
LEIsure Tourism Database (LEIsure)
MEDLINE/PubMed (NLM)
Protozoological Abstracts (Elsevier)
Review of Medical and Veterinary Mycology
Science Citation Index Expanded (also known as SciSearch)
Veterinary Bulletin (CABI)
ETA: List of references since they don't show on the talk page:
1. http://www.amjtrans.com/view/0/aims.html
2. http://atagc.med.ualberta.ca/Admin/Personnel/Director/Pages/default.aspx
3. http://www.emoryhealthcare.org/transplant-center/word-from-director.html
4. http://www.amjtrans.com/view/0/contact.html
5. Am J Transplant, Czech edition. Vol 3, Issue 3, 2013. Front matter.
6. Am J Transplant. Vol 13 Issue S3, 2013.
7. Am J Transplant. Vol 12 Issue S4, 2012.
8. http://srtr.transplant.hrsa.gov/who.aspx
9. http://2013.atcmeeting.org/abstract-information
10. Blumberg EA, Danziger-Isakov L, Kumar D, Michaels MG, and Razonable RR. Forward: Guidelines 3. Am J Transplant 2013; 13 (S4): 1-2.
11. http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291600-6143/homepage/images_in_transplantation.htm
Red (talk) (COI) 15:09, 5 December 2013 (UTC)
- Because reliable sources typically don't cover each other (or at least not neutrally), there is generally support for using weaker or primary sources for articles like this. While the text you propose looks ok, it is hard to tell the difference between the proposed text and the current article. I also noticed the proposed text seems to include a long list of subjects covered by the journal, which I think is unnecessary. This often comes from the desire to be comprehensive and technically accurate, whereas we need a summary. I would be inclined to make perhaps most of these edits for you if you can more clearly identify the changes. (sorry for the long wait in Request Edit. I prefer not to do these, but since nobody else is doing them, I guess someone has to) CorporateM (Talk) 17:26, 24 May 2014 (UTC)
- Frankly, like CorporateM, I have trouble seeing what exactly you want to have changed in the article. Most just seems a slight rewording of what is already there. Could you perhaps indicate more clearly what you want to change (instead of posting this alternative text)? For the moment, I don't see any reason to change anything... Thanks. --Randykitty (talk) 17:56, 24 May 2014 (UTC)
- The article currently posted is an edited version of the proposed text. It was actually updated shortly after I proposed the new text. I'm satisfied with the current article. Thank you both for your comments; I appreciate you taking the time to look over this. -- Red (talk) (COI) — Preceding undated comment added 15:33, 9 June 2014 (UTC)
- Frankly, like CorporateM, I have trouble seeing what exactly you want to have changed in the article. Most just seems a slight rewording of what is already there. Could you perhaps indicate more clearly what you want to change (instead of posting this alternative text)? For the moment, I don't see any reason to change anything... Thanks. --Randykitty (talk) 17:56, 24 May 2014 (UTC)
- Because reliable sources typically don't cover each other (or at least not neutrally), there is generally support for using weaker or primary sources for articles like this. While the text you propose looks ok, it is hard to tell the difference between the proposed text and the current article. I also noticed the proposed text seems to include a long list of subjects covered by the journal, which I think is unnecessary. This often comes from the desire to be comprehensive and technically accurate, whereas we need a summary. I would be inclined to make perhaps most of these edits for you if you can more clearly identify the changes. (sorry for the long wait in Request Edit. I prefer not to do these, but since nobody else is doing them, I guess someone has to) CorporateM (Talk) 17:26, 24 May 2014 (UTC)
References
- ^ "Director". Alberta Transplant Applied Genomics Centre. Retrieved 2013-12-3.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "A Word from Our Director". Emory Healthcare. Retrieved 2013-12-3.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Contact Us". Wiley-Blackwell. Retrieved 2013-12-3.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ American Journal of Transplantation, Czech edition. 3 (3). 2013.
{{cite journal}}
: Missing or empty|title=
(help) - ^ American Journal of Transplantation. 13 (S3). 2013.
{{cite journal}}
: Missing or empty|title=
(help) - ^ American Journal of Transplantation. 12 (S4). 2012.
{{cite journal}}
: Missing or empty|title=
(help) - ^ "About the SRTR". Health Resources and Services Administration. Retrieved 2013-12-3.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ "Abstract Information". American Transplant Congress. Retrieved 2013-12-3.
{{cite web}}
: Check date values in:|accessdate=
(help) - ^ Blumberg EA, Danziger-Isakov L, Kumar D, Michaels MG, and Razonable RR. (2013). ""Forward: Guidelines 3"". American Journal of Transplantation. 13 (S4): 1–2. doi:10.1111/ajt.12129. PMID 23464992.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "Images in Transplantation". Wiley-Blackwell. Retrieved 2013-12-5.
{{cite web}}
: Check date values in:|accessdate=
(help)